Dawid Dorna

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Cancer Stem Cells

Endoplasmic Reticulum Stress

Top Venues

Journal of cancer research and clinical oncology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells. Biomedicines 12 (6) (2024)
Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells. Biomedicines 12 (6) (2024)
Robert Kleszcz, Mikołaj Frąckowiak, Dawid Dorna, Jarosław Paluszczak
Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells. International journal of molecular sciences 24 (13) (2023)
Dawid Dorna, Jarosław Paluszczak
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers. Journal of cancer research and clinical oncology (2023)
Dawid Dorna, Jarosław Paluszczak
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers. Cells 11 (6) (2022)